Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 210,000 shares at $660.03 ($136.6M) on 2021-08-19, disclosed to the SEC on 2021-08-20.
Open-market sale of $136.6M REGN by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $650.03 | 200,000 | $130.0M | 95.2% |
| 2 | $660.03 | 10,000 | $6.6M | 4.8% |
| Total | $650.51 avg | 210,000 | $136.6M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |